25 results
8-K
EX-99.2
PYXS
Pyxis Oncology Inc
21 Mar 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
7:44am
and waste product removal; can also enable drug resistance that allows tumor to survive Why target the stroma? EDB+FN is a protein upregulated in tumor
424B3
x9k4s
30 Jun 23
Prospectus supplement
4:05pm
S-4/A
1z816tuem1ku2f5kqg3
29 Jun 23
Registration of securities issued in business combination transactions (amended)
4:09pm
S-4
ws3hnw jdz96afaj3d9
8 Jun 23
Registration of securities issued in business combination transactions
8:03am
425
umub cwhpqgh0au2r18j
24 May 23
Business combination disclosure
7:05am
425
4xdf8c 2r
24 May 23
Business combination disclosure
7:03am
8-K
EX-2.1
ugy2ur01
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
10-K
wbnaggmlb 0f5pts
29 Mar 22
Annual report
7:36am
10-Q
08hs 2detp
15 Nov 21
Quarterly report
7:54am
424B4
rtje qp9jus7sc
8 Oct 21
Prospectus supplement with pricing info
5:00pm